Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman

P. Mangiarotti, A. E. Taurino, A. M. Donnetta, F. Meloni, M. Barone, L. Casali (Pavia, Italy)

Source: Annual Congress 2001 - Pulmonary thromboembolism and infections
Session: Pulmonary thromboembolism and infections
Session type: Thematic Poster Session
Number: 2617
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Mangiarotti, A. E. Taurino, A. M. Donnetta, F. Meloni, M. Barone, L. Casali (Pavia, Italy). Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman. Eur Respir J 2001; 16: Suppl. 31, 2617

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM)
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008


The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010

Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL)
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012


Massive pulmonary embolism as the first manifestation in a patient with double heterozygocity for MTHFR and prothrombin 20210 G/A
Source: Eur Respir J 2003; 22: Suppl. 45, 443s
Year: 2003

Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis
Source: Eur Respir J 2003; 21: 25-30
Year: 2003



Prothrombin 20210 G/A mutation and EPCR I/D polymorphisms were rare in patients with pulmonary thromboembolism in Chinese Han population
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020
Year: 2020



The role of thrombophilic risk factors in the severity of pulmonary thromboembolism
Source: Eur Respir J 2002; 19: 709-711
Year: 2002



Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2008; 31: 736-741
Year: 2008



The acquired and inherited risk factors in venous thromboembolism (VTE)
Source: Eur Respir J 2003; 22: Suppl. 45, 220s
Year: 2003

D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia
Source: Eur Respir J 2006; 28: Suppl. 50, 46s
Year: 2006

Venous thromboembolic (VTE) in patients with ALS: an incidence study
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


Higher plasma total homocysteine (tHcy) level and abnormal methionine loading test (MLT) in family members of patients with pulmonary embolism (PE) and carriers of factor V Leiden (FVL)
Source: Annual Congress 2004 - Pulmonary embolism
Year: 2004


Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE)
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005

Inherited thrombophilia in the development of thrombotic conditions in patients with COPD
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021


Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza
Source: Eur Respir J 2010; 36: 1346-1354
Year: 2010



Age is a major risk factor of venous thromboembolism (VTE)
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011

Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008